Arylcyclohexylamine Explained

Arylcyclohexylamines, also known as arylcyclohexamines or arylcyclohexanamines, are a chemical class of pharmaceutical, designer, and experimental drugs.

History

Phencyclidine (PCP) is believed to be the first arylcyclohexylamine with recognized anesthetic properties, but several arylcyclohexylamines were described before PCP in the scientific literature, beginning with PCA (1-phenylcyclohexan-1-amine) the synthesis of which was first published in 1907. PCP itself was discovered in 1926 but not researched by pharmaceutical industry until the 1950s. PCE was reported in 1953 and PCMo (4-(1-phenyl-cyclohexyl)-morpholine[1] see chart below for figure) in 1954, with PCMo described as a potent sedative.[2] Arylcyclohexylamine anesthetics were intensively investigated at Parke-Davis, beginning with the 1956 studies of PCP and later the related compound ketamine.[2] The 1970s saw the debut of these compounds, especially PCP and its analogues, as illicitly used recreational drugs due to their dissociative hallucinogenic and euphoriant effects. Since that time, the class has been expanded by scientific research into stimulant, analgesic, and neuroprotective agents, and also by clandestine chemists in search of novel recreational drugs.[3] [4] [5]

Structure

An arylcyclohexylamine is composed of a cyclohexylamine unit with an aryl moiety attachment. The aryl group is positioned geminal to the amine. In the simplest cases, the aryl moiety is typically a phenyl ring, sometimes with additional substitution. The amine is usually not primary; secondary amines such as methylamine or ethylamine, or tertiary cycloalkylamines such as piperidine and pyrrolidine, are the most commonly encountered N-substituents.

Pharmacology

Arylcyclohexylamines varyingly possess NMDA receptor antagonistic,[6] [7] dopamine reuptake inhibitory,[8] and μ-opioid receptor agonistic[9] properties. Additionally, σ receptor agonistic,[10] nACh receptor antagonistic,[11] and D2 receptor agonistic[12] actions have been reported for some of these agents. Antagonism of the NMDA receptor confers anesthetic, anticonvulsant, neuroprotective, and dissociative effects; blockade of the dopamine transporter mediates stimulant and euphoriant effects as well as psychosis in high amounts; and activation of the μ-opioid receptor causes analgesic and euphoriant effects. Stimulation of the σ and D2 receptors may also contribute to hallucinogenic and psychotomimetic effects.[12]

These are versatile agents with a wide range of possible pharmacological activities depending on the extent and range to which chemical modifications are implemented.[13] [14] [15] [16] [17] [18] [19] [20] [21] The various choice of substitutions that are made allows for "fine-tuning" of the pharmacological profile that results. As examples, BTCP is a selective dopamine reuptake inhibitor,[8] PCP is primarily an NMDA antagonist,[6] and BDPC is a potent μ-opioid agonist,[22] while PRE-084 is a selective sigma receptor agonist.[23] Thus, radically different pharmacology is possible through different structural combinations.

Notes on numbering

PCP itself is composed of three six-membered rings, which can each be substituted by a variety of groups. These are traditionally numbered in the older research as first the cyclohexyl ring, then the phenyl, and finally the piperidine ring, with the different rings represented by prime notation (') next to the number. For instance, 4-methyl-PCP, 4'-methyl-PCP and 4''-methyl-PCP are all known compounds, with similar activity but quite different potencies.However, since the widespread sale of these compounds as grey-market designer drugs, nearly all such compounds that have come to prominence either have a bare cyclohexyl ring or a 2-ketocyclohexyl ring, while the piperidine is replaced by a variety of alkyl or cycloalkyl amines and most substitution has taken place on the phenyl ring. Consequently, it is common for widely used phenyl substituted analogues such as 3'-MeO-PCP and 3'-MeO-PCE to be referred to as 3-MeO-PCP and 3-MeO-PCE without the prime, even though this is technically incorrect and could lead to confusion.

List of arylcyclohexylamines

Structures ! data-sort-type="text" Compound ! data-sort-type="text" Aryl Substituent ! data-sort-type="text" N Group ! data-sort-type="text" Cyclohexyl ring ! CAS number - PCA[24] Phenyl NH2 - 1934-71-0 - PCM Phenyl Methylamino - 2201-16-3 - Phenyl Ethylamino - 2201-15-2 - PCPr[25] Phenyl n-Propylamino - 18949-81-0 - PCiP Phenyl Isopropylamino - 1195-42-2 - PCAL [26] Phenyl Allylamino - 2185-95-7 - PCBu Phenyl n-Butylamino - 73166-29-7 - PCEOH Phenyl Hydroxyethylamino - 2201-22-1 - PCMEA[27] Phenyl Methoxyethylamino - 2201-57-2 - PCEEA Phenyl Ethoxyethylamino - 1072895-05-6 - PCMPA Phenyl Methoxypropylamino - 2201-58-3 - PCDM Phenyl Dimethylamino - 2201-17-4 - Phenyl Diethylamino - 2201-19-6 - 2-HO-PCP Phenyl Piperidine2-Hydroxy 94852-58-1 - 2-Me-PCP[28] Phenyl Piperidine 2-Methyl 59397-29-4 - 2-MeO-PCP[29] Phenyl Piperidine 2-Methoxy 78636-34-7 - 2-Keto-PCP Phenyl Piperidine 2-Keto 101688-16-8 - Eticyclidone ("O-PCE") Phenyl Ethylamino 2-Keto 6740-82-5 - 2-Keto-PCPr Phenyl n-Propylamino 2-Keto - 4-Methyl-PCP Phenyl Piperidine 4-Methyl 19420-52-1 - 4-Keto-PCP[30] Phenyl Piperidine 4-Keto 65620-13-5 - 2'-Cl-PCP o-Chlorophenyl Piperidine - 2201-31-2 - m-Chlorophenyl Piperidine - 2201-32-3 - 2'-MeO-PCP o-Methoxyphenyl Piperidine - 2201-34-5 - 3'-F-PCP[31] m-Fluorophenyl Piperidine - 89156-99-0 - 3'-Me-PCP[32] m-Tolyl Piperidine - 2201-30-1 - m-Tolyl Pyrrolidine - 1622348-63-3 - 3'-NH2-PCP m-Aminophenyl Piperidine - 72242-00-3 - m-Hydroxyphenyl Piperidine - 79787-43-2 - m-Methoxyphenyl Piperidine - 72242-03-6 - 3,4-Methylenedioxyphenyl Piperidine - - m-Methoxyphenyl Ethylamino - 1364933-80-1 - 3'-HO-PCE m-Hydroxyphenyl Ethylamino - - 3'-MeO-PCPr m-Methoxyphenyl n-Propylamino - 1364933-81-2 - 3'-HO-PCPr m-Hydroxyphenyl n-Propylamino - - 3',4'-MD-PCPr 3,4-Methylenedioxyphenyl n-Propylamino - - 3'-MeO-PCPym-Methoxyphenyl Pyrrolidine - 1364933-79-8 - 4'-HO-PCP p-Hydroxyphenyl Piperidine - 66568-88-5 - Methoxydine (4'-MeO-PCP) p-Methoxyphenyl Piperidine - 2201-35-6 - 4'-MeO-PCEp-Methoxyphenyl Ethylamino - - 4'-F-PCP p-Fluorophenyl Piperidine - 22904-99-0 - 4'-F-PCPy p-Fluorophenyl Pyrrolidine - - o-Chlorophenyl Methylamino 2-Keto 33643-49-1 - Phenyl Methylamino 2-Keto 7063-30-1 - o-Chlorophenyl Methylamino 2-Keto 33643-46-8 - o-Chlorophenyl Methylamino 2-Keto 6740-88-1 - o-Chlorophenyl NH2 2-Keto, 6-Hydroxy 81395-70-2 - o-Chlorophenyl Ethylamino 2-Keto 1354634-10-8 - NPNK o-Chlorophenyl n-Propylamino 2-Keto 2749326-65-4 - o-Methoxyphenyl Methylamino 2-Keto 7063-51-6 - 2-MeO-NEK[33] o-Methoxyphenyl Ethylamino 2-Keto - oMDCK[34] o-Tolyl Methylamino 2-Keto 7063-37-8 - mMDCK m-Tolyl Methylamino 2-Keto - meta-Ketamine m-Chlorophenyl Methylamino 2-Keto 7063-53-8 - iso-Ketamine o-Chlorophenyl Methylamino 4-Keto - 2-Fluorodeschloroketamineo-Fluorophenyl Methylamino 2-Keto 111982-50-4 - m-Fluorophenyl Methylamino 2-Keto 2657761-23-2 - o-Bromophenyl Methylamino 2-Keto 120807-70-7 - o-Trifluoromethylphenyl Methylamino 2-Keto 1782149-73-8 - SN 35210[35] o-Chlorophenyl Carbomethoxybutylamino 2-Keto 1450615-41-4 - m-Methoxyphenyl Ethylamino 2-Keto 1239943-76-0 - m-Methoxyphenyl Methylamino 2-Keto 1781829-56-8 - m-Methoxyphenyl n-Propylamino 2-Keto 2504100-71-2 - m-Methoxyphenyl i-Propylamino 2-Keto - Ethoxetamine m-Ethoxyphenyl Ethylamino 2-Keto - Deoxymethoxetamine (3-Me-2'-Oxo-PCE) m-Tolyl Ethylamino 2-Keto 2666932-45-0 - Br-MXE 2-bromo-5-methoxyphenyl Ethylamino 2-Keto - Hydroxetamine (HXE) m-Hydroxyphenyl Ethylamino 2-Keto 1620054-73-0 - HXM m-Hydroxyphenyl Methylamino 2-Keto - o-Fluorophenyl Ethylamino 2-Keto - Fluorexetamine (FXE) m-Fluorophenyl Ethylamino 2-Keto - Phencyclidine (PCP) Phenyl Piperidine - 77-10-1 - PC3MP Phenyl 3-Methylpiperidine - 2201-41-4 - PC4MP Phenyl 4-Methylpiperidine - 2201-42-5 - Rolicyclidine (PCPy) Phenyl Pyrrolidine - 2201-39-0 - PCDMPy Phenyl 3,3-Dimethylpyrrolidine - - PCMo Phenyl Morpholine - 2201-40-3 - Methoxy-PCM (2'-MeO-PCMo) o-Methoxyphenyl Morpholine - 1314323-88-0 - m-Methoxyphenyl Morpholine - 138873-80-0 - 4'-MeO-PCMo p-Methoxyphenyl Morpholine - - Methyl-PCM[36] (4'-Me-PCMo) p-Tolyl Morpholine - 120803-52-3 - Hydroxy-methyl-PCM 2-Methyl-4-hydroxyphenyl Morpholine - 1314323-89-1 - PYCP [37] 2-Pyridinyl Piperidine - - TCM 2-Thienyl Methylamino - 139401-07-3 - TCE 2-Thienyl Ethylamino - 101589-62-2 - TCPr [38] 2-Thienyl Propylamino - - Tenocyclidine (TCP) 2-Thienyl Piperidine - 21500-98-1 - T3CP 3-Thienyl Piperidine - 19420-50-9 - TCPy 2-Thienyl Pyrrolidine - 22912-13-6 - 2-Thienyl Ethylamino 2-Keto 14176-49-9 - MXTE 4-Methoxy-2-thienyl Ethylamino 2-Keto - Piperidine 2-Methyl 68134-81-6 - p-Bromophenyl Dimethylamino 4-Phenethyl-4-hydroxy 77239-98-6 - p-Bromophenyl Dimethylamino 4-(thiophen-2-yl)ethyl-4-hydroxy 616898-54-5 - Dimetamine[39] p-Tolyl Dimethylamino 4-Keto 65619-06-9 - 3''-OH-2'-Me-PCP [40] o-Tolyl 3-Hydroxypiperidine - - 4''-Ph-4''-OH-PCP [41] || Phenyl || 4-Phenyl-4-hydroxypiperidine || - || 77179-39-6 |- | || BTCP[42] || Benzothiophen-2-yl || Piperidine || - || 112726-66-6 |- | || BTCPy || Benzothiophen-2-yl || Pyrrolidine || - || |- | || GK-189[43] || Naphthalen-2-yl || Piperidine || - || 81490-58-6 |- |}

Related compounds

Other similar compounds exist where the base ring has been varied, or the amine chain replaced with other groups.[44] More cycloalkane ring sizes have been experimented with than just purely thinking in terms of the cyclohexylamine. The cyclopentyl homologue of PCP is active with around one-tenth the potency,[45] while the cycloheptyl and cyclooctyl derivatives are inactive, though some substituted arylcycloheptylamines retain activity.[46] The requisite cycloalkylketone is reacted with PhMgBr; 3° alcohol is then reacted with NaN3; azide then reduced with LAH. Then in the final step the piperidine ring is constructed with 1-5-dibromo-pentane.[47] Other compounds are known where the cyclohexyl base ring is replaced by rings such as norbornyl, adamantyl,[48] tetralin, oxane, thiane [49] or piperidine.[50] Conformationally constrained analogs have been prepared and researched by Morieti et al.[51]

Structure ! data-sort-type="text" Compound ! data-sort-type="text" Aryl Substituent ! data-sort-type="text" N Group ! data-sort-type="text" Base ring ! CAS number - PCPEP Phenyl Piperidine Cyclopentyl 23036-19-3 - 3F-PCHEPy 3-Fluorophenyl Pyrrolidine Cycloheptyl - 3-MeO-PBCHP 3-Methoxyphenyl Piperidine Bicyclo[2.2.1]heptane - PADP (P2AP) Phenyl Piperidine Adamantyl 72241-99-7 - 3-MeO-PTP 3-Methoxyphenyl Piperidine Tetralin - HHFA Fused phenyl Amino Hexahydrofluorene - DHPQ Phenyl Decahydroquinoline - POXP Phenyl Piperidine Oxane - PTHP Phenyl Piperidine Thiane - MPBPip Phenyl Piperidine N-Methylpiperidine 36882-04-9 - BnCP Benzyl Piperidine Cyclohexyl 22912-07-8 - YNCP Ethynyl Piperidine Cyclohexyl 51165-02-7 - ALCP Allyl Piperidine Cyclohexyl 7418-80-6 - Replaced by carboxamide Piperidine N-(3-cyano-3,3-diphenylpropyl)piperidine 302-41-0 - Phenyl Morpholinylethylcarboxylate Cyclohexyl 138847-85-5 - p-Chlorophenyl Diethylaminoethoxy Cyclohexyl 5632-52-0 -

Further reading

  • Morris H, Wallach J . From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs . Drug Testing and Analysis . 6 . 7–8 . 614–32 . 2014 . 24678061 . 10.1002/dta.1620 .

External links

]

Notes and References

  1. Web site: 4-(1-phenyl-cyclohexyl)-morpholine . CAS Number Search - chemsrc.com . chemsrc . 15 March 2021.
  2. Morris H, Wallach J . From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs . Drug Testing and Analysis . 6 . 7–8 . 614–32 . 2014 . 24678061 . 10.1002/dta.1620 .
  3. Book: Valter K, Arrizabalaga P . Designer Drugs Directory . Elsevier . 1998 . 0-444-20525-X.
  4. Book: Wallach J, Brandt SD . Phencyclidine-Based New Psychoactive Substances . 252. 261–303. August 2018 . 30105474 . 10.1007/164_2018_124. Handbook of Experimental Pharmacology . 978-3-030-10560-0 . New Psychoactive Substances .
  5. Book: Wallach J, Brandt SD . New Psychoactive Substances . 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances . Handbook of Experimental Pharmacology . 252 . 305–352 . 2018 . 30196446 . 10.1007/164_2018_148 . 978-3-030-10560-0 .
  6. Ahmadi A, Mahmoudi A . Synthesis and biological properties of 2-hydroxy-1-(1-phenyltetralyl)piperidine and some of its intermediates as derivatives of phencyclidine . Arzneimittel-Forschung . 55 . 9 . 528–32 . 2005 . 16229117 . 10.1055/s-0031-1296900 . 29006399 .
  7. Ahmadi A, Khalili M, Hajikhani R, Naserbakht M . New morpholine analogues of phencyclidine: chemical synthesis and pain perception in rats . Pharmacology, Biochemistry, and Behavior . 98 . 2 . 227–33 . April 2011 . 21215770 . 10.1016/j.pbb.2010.12.019 . 24650035 .
  8. Chaudieu I, Vignon J, Chicheportiche M, Kamenka JM, Trouiller G, Chicheportiche R . Role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by PCP analogs . Pharmacology, Biochemistry, and Behavior . 32 . 3 . 699–705 . March 1989 . 2544905 . 10.1016/0091-3057(89)90020-8 . 7672918 .
  9. Itzhak Y, Simon EJ . A novel phencyclidine analog interacts selectively with mu opioid receptors . The Journal of Pharmacology and Experimental Therapeutics . 230 . 2 . 383–6 . August 1984 . 6086884 .
  10. He XS, Raymon LP, Mattson MV, Eldefrawi ME, de Costa BR . Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites . Journal of Medicinal Chemistry . 36 . 9 . 1188–93 . April 1993 . 8098066 . 10.1021/jm00061a009 .
  11. Eterović VA, Lu R, Eakin AE, Rodríguez AD, Ferchmin PA . Determinants of phencyclidine potency on the nicotinic acetylcholine receptors from muscle and electric organ . Cellular and Molecular Neurobiology . 19 . 6 . 745–57 . December 1999 . 10456235 . 10.1023/A:1006905106834 . 22266452 . free .
  12. Seeman P, Ko F, Tallerico T . Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics . Molecular Psychiatry . 10 . 9 . 877–83 . September 2005 . 15852061 . 10.1038/sj.mp.4001682 .
  13. al-Deeb OA . New analgesics derived from the phencyclidine analogue thienylcyclidine . Arzneimittel-Forschung . 46 . 5 . 505–8 . May 1996 . 8737636 .
  14. Ahmadi A, Khalili M, Hajikhani R, Hosseini H, Afshin N, Nahri-Niknafs B . Synthesis and study the analgesic effects of new analogues of ketamine on female wistar rats . Medicinal Chemistry . 8 . 2 . 246–51 . March 2012 . 22385170 . 10.2174/157340612800493683 . 42842315 .
  15. Ahmadi A, Khalili M, Abbassi S, Javadi M, Mahmoudi A, Hajikhani R . Synthesis and study on analgesic effects of 1-[1-(4-methylphenyl) (cyclohexyl)] 4-piperidinol and 1-[1-(4-methoxyphenyl) (cyclohexyl)] 4-piperidinol as two new phencyclidine derivatives . Arzneimittel-Forschung . 59 . 4 . 202–6 . 2009 . 19517897 . 10.1055/s-0031-1296386 . 5402425 .
  16. Ahmadi A, Khalili M, Marami S, Ghadiri A, Nahri-Niknafs B . Synthesis and pain perception of new analogues of phencyclidine in NMRI male mice . Mini Reviews in Medicinal Chemistry . 14 . 1 . 64–71 . January 2014 . 24251803 . 10.2174/1389557513666131119203551 .
  17. Ahmadi A, Solati J, Hajikhani R, Pakzad S . Synthesis and analgesic effects of new pyrrole derivatives of phencyclidine in mice . Arzneimittel-Forschung . 61 . 5 . 296–300 . 2011 . 21755813 . 10.1055/s-0031-1296202 . 24287727 .
  18. Ahmadi A, Khalili M, Hajikhani R, Barghi L, Mihandoust F . Synthesis and determination of chronic and acute thermal and chemical pain activities of a new derivative of phencyclidine in rats . Iranian Journal of Pharmaceutical Research . 9 . 4 . 379–85 . 2010 . 24381602 . 3870061 .
  19. Ahmadi A, Khalili M, Mihandoust F, Barghi L . Synthesis and determination of acute and chronic pain activities of 1-[1-(3-methylphenyl) (tetralyl)]piperidine as a new derivative of phencyclidine via tail immersion and formalin tests . Arzneimittel-Forschung . 60 . 1 . 30–5 . 2010 . 20184224 . 10.1055/s-0031-1296245 . 23966936 .
  20. Hajikhani R, Ahmadi A, Naderi N, Yaghoobi K, Shirazizand Z, Rezaee NM, Niknafs BN . Effect of phencyclidine derivatives on anxiety-like behavior using an elevated-plus maze test in mice . Advances in Clinical and Experimental Medicine . 21 . 3 . 307–12 . 2012 . 23214193 .
  21. Ahmadi A, Khalili M, Mirza B, Mohammadi-Diz M, Azami-Lorestani F, Ghaderi P, Nahri-Niknafs B . Synthesis and Antinociception Activities of Some Novel Derivatives of Phencyclidine with Substituted Aminobenzothiazoles . Mini Reviews in Medicinal Chemistry . 17 . 1 . 78–84 . 2017 . 27121715 . 10.2174/1389557516666160428112532 .
  22. Lednicer D, VonVoigtlander PF . 4-(p-Bromophenyl)-4-(dimethylamino)-1-phenethylcyclohexanol, an extremely potent respresentative of a new analgesic series . Journal of Medicinal Chemistry . 22 . 10 . 1157–8 . October 1979 . 513062 . 10.1021/jm00196a001 .
  23. Maurice T, Su TP, Parish DW, Nabeshima T, Privat A . PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice . Pharmacology, Biochemistry, and Behavior . 49 . 4 . 859–69 . December 1994 . 7886099 . 10.1016/0091-3057(94)90235-6 . 54306053 .
  24. Thurkauf A, de Costa B, Yamaguchi S, Mattson MV, Jacobson AE, Rice KC, Rogawski MA . Synthesis and anticonvulsant activity of 1-phenylcyclohexylamine analogues . Journal of Medicinal Chemistry . 33 . 5 . 1452–8 . May 1990 . 2329567 . 10.1021/jm00167a027 .
  25. Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH . Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry . Journal of Chromatography A . 1186 . 1–2 . 380–90 . April 2008 . 18035363 . 10.1016/j.chroma.2007.11.002 .
  26. Kalir A, Teomy S, Amir A, Fuchs P, Lee SA, Holsztynska EJ, Rocki W, Domino EF . 6 . N-allyl analogues of phencyclidine: chemical synthesis and pharmacological properties . Journal of Medicinal Chemistry . 27 . 10 . 1267–71 . October 1984 . 6481761 . 10.1021/jm00376a006 .
  27. Sauer C, Peters FT, Schwaninger AE, Meyer MR, Maurer HH . Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine . Biochemical Pharmacology . 77 . 3 . 444–50 . February 2009 . 19022226 . 10.1016/j.bcp.2008.10.024 .
  28. Iorio MA, Tomassini L, Mattson MV, George C, Jacobson AE . Synthesis, stereochemistry, and biological activity of the 1-(1-phenyl-2-methylcyclohexyl)piperidines and the 1-(1-phenyl-4-methylcyclohexyl)piperidines. Absolute configuration of the potent trans-(-)-1-(1-phenyl-2-methylcyclohexyl)piperidine . Journal of Medicinal Chemistry . 34 . 8 . 2615–23 . August 1991 . 1875352 . 10.1021/jm00112a041 .
  29. Ahmadi A, Mahmoudi A . Synthesis with improved yield and study on the analgesic effect of 2-methoxyphencyclidine . Arzneimittel-Forschung . 56 . 5 . 346–50 . 2006 . 16821645 . 10.1055/s-0031-1296732 . 10370245 .
  30. Ortiz DM, Custodio RJ, Abiero A, Botanas CJ, Sayson LV, Kim M, Lee HJ, Kim HJ, Jeong Y, Yoon S, Lee YS, Cheong JH . 6 . The dopaminergic alterations induced by 4-F-PCP and 4-Keto-PCP may enhance their drug-induced rewarding and reinforcing effects: Implications for abuse . Addiction Biology . 26 . 4 . e12981 . July 2021 . 33135332 . 10.1111/adb.12981 . 226234538 .
  31. 10.1016/S0022-1139(01)00565-6. Syntheses of fluorinated phencyclidine analogs. Journal of Fluorine Chemistry. 114. 39–42. 2002. Ogunbadeniyi AM, Adejare A .
  32. Wallach J, De Paoli G, Adejare A, Brandt SD . Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues . Drug Testing and Analysis . 6 . 7–8 . 633–50 . 2013 . 23554350 . 10.1002/dta.1468 .
  33. Sayson LV, Botanas CJ, Custodio RJ, Abiero A, Kim M, Lee HJ, Kim HJ, Yoo SY, Lee KW, Ryu HW, Acharya S, Kim KM, Lee YS, Cheong JH . 6 . The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors . Psychopharmacology . 236 . 7 . 2201–2210 . July 2019 . 30891619 . 10.1007/s00213-019-05219-x . 83463722 .
  34. WO . 2021134086. Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders . Kruegel AC, Sames D, Hashimoto K . Gilgamesh Pharmaceuticals, Inc. . The Trustees Of Columbia University In The City Of New York . 1 July 2021 . . .
  35. Harvey M, Sleigh J, Voss L, Pruijn F, Jose J, Gamage S, Denny W . Determination of the Hypnotic Potency in Rats of the Novel Ketamine Ester Analogue SN 35210 . Pharmacology . 96 . 5–6 . 226–32 . 2015 . 26352278 . 10.1159/000439598 . 36017002 .
  36. Ahmadi A, Khalili M, Hajikhani R, Naserbakht M . Synthesis and determination of acute and chronic pain activities of 1-[1-(4-methylphenyl) (cyclohexyl)] morpholine as a new phencyclidine derivative in rats . Arzneimittel-Forschung . 61 . 2 . 92–7 . 2011 . 21428243 . 10.1055/s-0031-1296173 . 8094521 .
  37. Zarantonello P, Bettini E, Paio A, Simoncelli C, Terreni S, Cardullo F . Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists . Bioorganic & Medicinal Chemistry Letters . 21 . 7 . 2059–63 . April 2011 . 21334205 . 10.1016/j.bmcl.2011.02.009 .
  38. Wallach J, Colestock T, Cicali B, Elliott SP, Kavanagh PV, Adejare A, Dempster NM, Brandt SD . 6 . Syntheses and analytical characterizations of N-alkyl-arylcyclohexylamines . Drug Testing and Analysis . 8 . 8 . 801–15 . August 2016 . 26360516 . 10.1002/dta.1861 . 1599386 .
  39. Lednicer D, VonVoigtlander PF, Emmert DE . 4-Amino-4-arylcyclohexanones and their derivatives, a novel class of analgesics. 1. Modification of the aryl ring . Journal of Medicinal Chemistry . 23 . 4 . 424–30 . April 1980 . 7381841 . 10.1021/jm00178a014 .
  40. Ahmadi A, Solati J, Hajikhani R, Onagh M, Javadi M . Synthesis and analgesic effects of 1-[1-(2-methylphenyl)(cyclohexyl)]-3-piperidinol as a new derivative of phencyclidine in mice . Arzneimittel-Forschung . 60 . 8 . 492–6 . 2010 . 20863005 . 10.1055/s-0031-1296317 . 24803623 .
  41. Itzhak Y, Kalir A, Weissman BA, Cohen S . New analgesic drugs derived from phencyclidine . Journal of Medicinal Chemistry . 24 . 5 . 496–9 . May 1981 . 7241506 . 10.1021/jm00137a004 .
  42. Vignon J, Pinet V, Cerruti C, Kamenka JM, Chicheportiche R . [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex . European Journal of Pharmacology . 148 . 3 . 427–36 . April 1988 . 3384005 . 10.1016/0014-2999(88)90122-7 .
  43. https://patents.google.com/patent/US5248686A Kamenka JM, et al. Substituted cyclic amines and pharmaceutical composition containing them. Patent US5248686, 28 September 1993
  44. Wallach JV. Structure activity relationship (SAR) studies of arylcycloalkylamines as N-methyl-D-aspartate receptor antagonists. PhD. Thesis, University of the Sciences in Philadelphia, 19 Dec 2014.
  45. Shulgin AT, Mac Lean DE . Illicit synthesis of phencyclidine (PCP) and several of its analogs . Clinical Toxicology . 9 . 4 . 553–60 . 1976 . 975751 . 10.3109/15563657608988157 .
  46. Sun S, Wallach J, Adejare A . Syntheses and N-methyl-D-aspartate receptor antagonist pharmacology of fluorinated arylcycloheptylamines . Medicinal Chemistry . Shariqah (United Arab Emirates) . 10 . 8 . 843–52 . 2014 . 24773376 . 10.2174/1573406410666140428104444 .
  47. McQuinn RL, Cone EJ, Shannon HE, Su TP . Structure-activity relationships of the cycloalkyl ring of phencyclidine . Journal of Medicinal Chemistry . 24 . 12 . 1429–32 . December 1981 . 7310819 . 10.1021/jm00144a011 .
  48. Eaton TA, Houk KN, Watkins SF, Fronczek FR . Geometries and conformational processes in phencyclidine and a rigid adamantyl analogue: variable-temperature NMR, X-ray crystallographic, and molecular mechanics studies . Journal of Medicinal Chemistry . 26 . 4 . 479–86 . April 1983 . 6834381 . 10.1021/jm00358a005 .
  49. https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/62c743ca638326c3ed445d91/original/identification-and-characterization-of-designer-phencyclidines-pc-ps-in-forensic-casework.pdf Sisco E, Urbas A. Identification and Characterization of Designer Phencyclidines (PCPs) in Forensic Casework
  50. https://patents.google.com/patent/US3311624A Gerhard O, Eberhard E. 4-amino-piperidines. US3311624A
  51. Moriarty RM, Enache LA, Zhao L, Gilardi R, Mattson MV, Prakash O . Rigid phencyclidine analogues. Binding to the phencyclidine and sigma 1 receptors . Journal of Medicinal Chemistry . 41 . 4 . 468–77 . February 1998 . 9484497 . 10.1021/jm970059p .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Arylcyclohexylamine".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.